Highland Capital Management (Texas)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Highland Capital Management (Texas)'s BMY Position: Q2 2019 in Review
Highland Capital Management (Texas) opened a new position in Bristol-Myers Squibb (BMY) in Q2 2019: 318,200 shares worth $14.4M. The stake represents 0.84% of the portfolio and ranks #20 among its holdings. This is a return to the name: Highland Capital Management (Texas) previously reported a position in BMY as recently as Q3 2017.
Highland Capital Management (Texas) first reported a position in BMY in Q1 2014 and has held it in 7 quarters since. The position peaked at $35.6M in Q4 2015. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.
- Highland Capital Management (Texas) held 318,200 shares of Bristol-Myers Squibb worth $14.4M as of Q2 2019.
- Bristol-Myers Squibb was a new Highland Capital Management (Texas) position in Q2 2019.
- Bristol-Myers Squibb made up 0.84% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #20 holding.
- Highland Capital Management (Texas) first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 7 quarters since.
- Highland Capital Management (Texas)'s Bristol-Myers Squibb position peaked at $35.6M in Q4 2015.
- 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.
Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.